Dexmedetomidine Hydrochloride

Dexmedetomidine Hydrochloride

The company are committed to becoming a world-class high-end biopharmacetical API service provider.

  • Cas NO.： 145108-58-3
  • Indication： Sedation

Classification:

API

yctr@renfu.com.cn

Inquiry
Related

Yichang Tianrui Biopharm Co., LTD. (Tianrui Biopharm), a wholly-owned subsidiary of Yichang Renfu Pharmaceutical Co., LTD., was established in November 2022, located in Baiyang Biological Industrial Park, Yichang High-tech Development Zone, Hubei Province.

Tianrui Biopharm with a total investment of about 3 million USD and a total land area of 22000㎡, design 13 GMP workshops, divided into three phases of construction. The company is mainly engaged in the research and development, production and sales of high-end APIs (including intermediates). At present, the first phase construction has been completed with an investment of about 120 million USD. There are 2 GMP commercial workshops with 9 production lines. With the main business of research, production, CMO and CDMO of high-end APIs, the company are committed to becoming a world-class high-end biopharmacetical API service provider.

Keywords:

API

INTERMEDIATES

Related Products

4-chloro-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine

4-chloro-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine

(E)-3-(3-fluoro-2-(3-(2-methoxy-5(trifl uoromethyl)phenyl)ureido)phenyl) methylacrylate

(E)-3-(3-fluoro-2-(3-(2-methoxy-5(trifl uoromethyl)phenyl)ureido)phenyl) methylacrylate

1-(1,1-Dimethylethyl)-1H-1,2,3-triazole-4-carboxylic acid

1-(1,1-Dimethylethyl)-1H-1,2,3-triazole-4-carboxylic acid

2-(2-amino-5-bromobenzoyl)pyridine

2-(2-amino-5-bromobenzoyl)pyridine

Get a Product Quote

Our staff will contact you within 24 hours (working days) for any additional services.
Submit